Literature DB >> 16444771

'Hy's law,' the 'Rezulin Rule,' and other predictors of severe drug-induced hepatotoxicity: putting risk-benefit into perspective.

James H Lewis1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16444771     DOI： 10.1002/pds.1209

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN： 1053-8569            Impact factor:   2.890


× No keyword cloud information.
  10 in total

1.  A safety grading scale to support dose escalation and define stopping rules for healthy subject first-entry-into-man studies: some points to consider from the French Club Phase I working group.

Authors:  Michel Sibille; Alain Patat; Henri Caplain; Yves Donazzolo
Journal:  Br J Clin Pharmacol       Date:  2010-11       Impact factor: 4.335

Review 2.  Idiosyncratic drug-induced liver injury: a clinical update.

Authors:  Haripriya Maddur; Naga Chalasani
Journal:  Curr Gastroenterol Rep       Date:  2011-02

3.  The adaptive response (drug tolerance) helps to prevent drug-induced liver injury.

Authors:  James H Lewis
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-05

Review 4.  The Origins of the Modern-Day Study of Drug Hepatotoxicity: Focus on Hyman J. Zimmerman.

Authors:  James H Lewis; Leonard B Seeff
Journal:  Clin Liver Dis (Hoboken)       Date:  2020-03-02

5.  Incidence of potential drug interactions in medication prescriptions for children and adolescents in the University Hospital Olomouc, Czech Republic.

Authors:  Petra Langerová; Michal Prokeš; Martin Konvalinka; Jana Fürstová; Karel Urbánek
Journal:  Eur J Pediatr       Date:  2013-01-19       Impact factor: 3.183

6.  Clinical pattern of zileuton-associated liver injury: results of a 12-month study in patients with chronic asthma.

Authors:  Paul B Watkins; Louise M Dube; Karen Walton-Bowen; Christopher M Cameron; Linda E Kasten
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 7.  Current and future directions in the treatment and prevention of drug-induced liver injury: a systematic review.

Authors:  Jonathan G Stine; James H Lewis
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2015-12-25       Impact factor: 3.869

Review 8.  Enoxaparin-Induced Liver Injury: Case Report and Review of the Literature and FDA Adverse Event Reporting System (FAERS).

Authors:  Katherine J Hahn; Shannon J Morales; James H Lewis
Journal:  Drug Saf Case Rep       Date:  2015-12

Review 9.  Drug-induced liver injury: recent advances in diagnosis and risk assessment.

Authors:  Gerd A Kullak-Ublick; Raul J Andrade; Michael Merz; Peter End; Andreas Benesic; Alexander L Gerbes; Guruprasad P Aithal
Journal:  Gut       Date:  2017-03-23       Impact factor: 23.059

Review 10.  Clinical Significance of Transient Asymptomatic Elevations in Aminotransferase (TAEAT) in Oncology.

Authors:  James H Lewis; Sophia K Khaldoyanidi; Carolyn D Britten; Andrew H Wei; Marion Subklewe
Journal:  Am J Clin Oncol       Date:  2022-07-18       Impact factor: 2.787
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.